首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

2044466

寵物過敏護理市場預測至2034年—按過敏類型、治療方法、給藥途徑、寵物品種、分銷管道和地區分類的全球分析

Pet Allergy Care Market Forecasts to 2034 - Global Analysis By Allergy Type, Treatment Type, Route of Administration, Pet Type, Distribution Channel, and By Geography

出版日期: 2026年05月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計到 2026 年，全球寵物過敏護理市場規模將達到 23 億美元，並在預測期內以 8.4% 的複合年成長率成長，到 2034 年將達到 44 億美元。

寵物過敏護理涵蓋對伴侶動物（例如犬貓）過敏反應的診斷、管理和治療，這些動物的過敏症狀與人類相似。該市場包括藥物療法、免疫療法、外用療法和飲食管理策略，旨在緩解搔癢、皮膚發炎、呼吸困難和胃腸道問題等症狀。在全球範圍內，寵物飼養量的成長、人們對動物健康的日益關注以及對先進獸醫護理投資意願的增強，正在推動這一專業醫療保健領域的擴張。

全球寵物飼養數量的增加以及寵物在家庭中的地位日益提升。

如今，全球數百萬家庭將寵物視為家庭成員，這導致他們在高品質獸醫護理和過敏管理方面的支出不斷增加。寵物飼主越來越傾向於尋求專業診斷和持續治療，以解決過去被認為輕微或無法治癒的疾病，並且更加關注寵物的不適徵兆。這種情感紐帶促使他們願意投資先進的治療方法，包括免疫療法和特殊飲食，即使這些治療需要長期投入和高昂費用。獸醫診所報告稱，諮詢量增加，尤其是與過敏相關的諮詢，這反映出過敏症的盛行率不斷上升，以及飼主對現有治療方法方案的了解日益增多。

高級過敏治療費用高昂

長期治療方案，尤其是免疫療法和處方飲食計劃，會給寵物飼主帶來沉重的經濟負擔。與一次性手術不同，過敏治療通常需要反覆復診以監測療效，持續更新處方箋藥物，並定期進行診斷測試。寵物保險對過敏性疾病的承保範圍差異很大，許多保單不承保慢性既往疾病，或者設定終身賠償限額，而持續的治療計劃很快就會達到這些限額。這些經濟現實迫使一些飼主放棄最佳治療方案，轉而選擇療效較差但價格更低的替代方案；在嚴重的情況下，他們甚至會考慮為那些過敏症狀難以控制的寵物尋找新家。

新型生物製藥和標靶免疫療法的開發

製藥公司正致力於研發新一代治療方法，旨在解決潛在的免疫功能障礙，而不僅僅是抑制症狀。針對犬類過敏性搔癢關鍵介質白細胞介素-31的特異性單株抗體，與傳統皮質類固醇相比，療效較佳，副作用較少。基於個別過敏測試的個人化免疫療法製劑，由於生產成本降低和獸醫皮膚病學專業知識的不斷積累，正變得越來越普及。這些創新有望改善過敏寵物的生命質量，同時減少就診次數，從而創造價值提案，使其能夠支撐高價，並推動其在寵物飼主中的市場滲透。

獸醫皮膚科專家短缺

在許多地區，認證獸醫皮膚科醫生的數量有限，嚴重限制了複雜過敏病例的診斷和治療。全科獸醫可能缺乏過敏測試方案和免疫療法製劑的專業培訓，導致治療方案欠佳或干涉措施延誤。預約專科醫生的漫長等待時間會加重過敏症狀，使治療更加複雜，並降低治療效果。在農村地區和醫療資源匱乏的都市區，獲得專科醫療服務尤其困難，這限制了需要專科醫生指導的先進治療方法的市場普及。同時，遠端醫療的替代方案仍然受到監管和診斷限制。

新冠疫情的影響：

新冠疫情初期，由於封鎖措施限制了非緊急就診，常規獸醫服務受到衝擊，非緊急過敏性疾病的診斷率暫時下降。然而，隨後寵物領養數量的激增，以及遠距辦公的普及使飼主能夠更密切地觀察寵物的行為，最終加速了過敏症護理市場的成長。由於在家工作時間增多，飼主更加關注先前可能被忽視的細微抓癢、舔舐和呼吸道症狀，從而導致就診量增加。遠端保健的引入使得對病情穩定的過敏症患者進行初步評估和持續監測成為可能，同時還可以透過電商平台直接配送處方糧和維持用藥。這重塑了醫療服務模式，並對治療的可近性產生了持久的正面影響。

在預測期內，環境過敏領域預計將佔據最大的市場佔有率。

預計在預測期內，環境過敏領域將佔據最大的市場佔有率。這反映了伴侶動物廣泛接觸常見過敏原，例如花粉、塵蟎、黴菌孢子和草類。與需要特定飲食因素的食物過敏不同，環境過敏原無所不在，室內外皆有，因此大多數寵物幾乎不可能完全避免接觸。季節性過敏加重需要反覆就診和持續治療，從而在所有地區都維持對抗組織胺、皮質類固醇和免疫療法的穩定需求。氣候變遷導致環境過敏原水平上升，以及多個大洲花粉季延長，進一步鞏固了該領域的領先地位。

預計在預測期內，免疫療法領域將呈現最高的複合年成長率。

在預測期內，免疫療法領域預計將呈現最高的成長率，這主要得益於其獨特的優勢：它能夠直接改變潛在的過敏反應，而不僅僅是暫時抑制症狀。該療法透過皮內注射和血清學檢測來確定特定的過敏原，並逐步增加劑量，以訓練免疫系統逐漸產生耐受性。治療方案通常持續12至18個月，療程結束後，患者可獲得持續的症狀緩解，與終身對症治療相比，具有更優的長期療效。舌下給藥技術的進步，無需前往醫院注射，即可在家中給藥，提高了患者的治療依從性，並擴大了適用人群。獸醫皮膚科醫生正擴大推薦免疫療法作為中重度環境過敏的一線治療方法。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其較高的寵物擁有率、完善的獸醫基礎設施以及消費者在伴侶動物健康方面的強勁支出。該地區先進的獸醫皮膚病專家網路使都市區和郊區的寵物飼主能夠獲得全面的過敏測試和個人化的免疫療法。專注於動物用藥品的大型製藥企業正在美國進行大規模的研究和商業活動，確保新治療方法的快速上市。雖然寵物保險的普及率仍然不高，但北美高於大多數其他地區，一些保險公司提供過敏診斷和長期管理方案的專項保險。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、印度和韓國等國家中產階級寵物家庭數量的快速成長。都市化雖然增加了人們接觸環境污染物和室內過敏原的機會，但生活方式的改變也加深了人與寵物之間的聯繫，從而推動了對獸醫服務的需求，使其與西方市場的需求相媲美。獸醫教育基礎設施正在不斷完善，專攻皮膚病學和過敏症管理的獸醫數量也在增加。國際製藥公司正在根據當地市場需求調整產品系列，包括開發適合區域過敏原特徵的配方，並建立區域分銷網路，這些都使亞太地區成為寵物過敏治療領域成長最快的前沿陣地。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Zoetis Inc.
Elanco Animal Health Incorporated
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Virbac SA
Dechra Pharmaceuticals PLC
Ceva Sante Animale
Heska Corporation
Vetoquinol SA
IDEXX Laboratories, Inc.
PetIQ, Inc.
Allergan plc
Nestle Purina PetCare Company
Hill's Pet Nutrition, Inc.
Royal Canin SAS
Kindred Biosciences, Inc.
Nextmune Holding BV

簡介目錄圖表

Product Code: SMRC36255

According to Stratistics MRC, the Global Pet Allergy Care Market is accounted for $2.3 billion in 2026 and is expected to reach $4.4 billion by 2034 growing at a CAGR of 8.4% during the forecast period. Pet allergy care encompasses the diagnosis, management, and treatment of allergic reactions in companion animals, including dogs and cats, which suffer from conditions similar to human allergies. The market includes pharmacological interventions, immunotherapy, topical treatments, and dietary management strategies designed to alleviate symptoms such as itching, skin inflammation, respiratory distress, and gastrointestinal disturbances. Rising pet ownership, increasing awareness of animal health, and growing willingness to invest in advanced veterinary care are driving the expansion of this specialized healthcare segment globally.

Market Dynamics:

Driver:

Rising global pet ownership and humanization of pets

Millions of households worldwide now consider companion animals as family members, leading to increased spending on premium veterinary care and allergy treatments. Pet owners are increasingly attentive to signs of discomfort in their animals, seeking professional diagnosis and ongoing management for conditions once considered minor or untreatable. This emotional bond translates into willingness to invest in advanced therapies, including immunotherapy and specialized diets, even when treatments require long-term commitment and substantial financial outlay. Veterinary clinics report rising consultation volumes specifically for allergy-related concerns, reflecting both increased disease prevalence and heightened owner awareness of available treatment options.

Restraint:

High cost of advanced allergy treatments

Long-term management protocols, particularly immunotherapy and prescription dietary plans, impose significant financial burdens on pet owners over extended periods. Unlike one-time surgical procedures, allergy care often requires repeated consultations, ongoing medication refills, and periodic diagnostic testing to monitor treatment efficacy. Pet insurance coverage for allergy conditions varies widely, with many policies excluding chronic pre-existing conditions or imposing lifetime benefit caps that quickly exhaust under continuous treatment protocols. These economic realities force some owners to discontinue optimal therapies in favor of less effective but more affordable alternatives, or in severe cases, consider rehoming animals with unmanageable allergic conditions.

Opportunity:

Development of novel biologics and targeted immunotherapies

Pharmaceutical companies are advancing next-generation treatments that address underlying immune dysfunction rather than merely suppressing symptoms. Canine-specific monoclonal antibodies targeting interleukin-31, a key mediator of allergic itch, have demonstrated superior efficacy with fewer side effects compared to conventional corticosteroids. Customized immunotherapy formulations based on individual patient allergy testing are becoming more accessible as production costs decrease and veterinary dermatology expertise expands. These innovations promise improved quality of life for allergic pets while potentially reducing the frequency of veterinary visits, creating value propositions that justify premium pricing and drive market adoption among dedicated pet owners.

Threat:

Shortage of specialized veterinary dermatologists

Limited availability of board-certified veterinary dermatologists creates significant bottlenecks in the diagnosis and management of complex allergy cases across many regions. Primary care veterinarians may lack advanced training in allergy testing protocols and immunotherapy formulation, potentially leading to suboptimal treatment plans or delayed intervention. Long waiting periods for specialist appointments allow allergic conditions to worsen, complicating management and potentially reducing treatment responsiveness. Rural and underserved metropolitan areas face particular challenges in accessing specialized care, limiting market penetration for advanced treatment modalities that require specialist oversight, while telemedicine alternatives remain constrained by regulatory and diagnostic limitations.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted routine veterinary services as lockdowns limited non-emergency consultations, temporarily reducing diagnosis rates for non-urgent allergy conditions. However, the subsequent surge in pet adoptions, combined with remote work arrangements that increased owner observation of pet behaviors, ultimately accelerated the allergy care market. Pet owners spending more time at home noticed subtle scratching, licking, and respiratory signs that might previously have gone undetected, driving increased consultation volumes. Telehealth adoption enabled preliminary assessments and ongoing monitoring for stable allergy patients, while e-commerce platforms facilitated direct delivery of prescription diets and maintenance medications, reshaping care delivery models with lasting positive effects on treatment accessibility.

The Environmental Allergies segment is expected to be the largest during the forecast period

The Environmental Allergies segment is expected to account for the largest market share during the forecast period, reflecting the pervasive exposure of companion animals to common allergens including pollen, dust mites, mold spores, and grass species. Unlike food allergies which require specific dietary triggers, environmental allergens are ubiquitous in both indoor and outdoor settings, making complete avoidance practically impossible for most pets. Seasonal flare-ups prompt recurring veterinary visits and ongoing management requirements, sustaining consistent demand for antihistamines, corticosteroids, and immunotherapy across all geographic regions. The segment's dominance is further reinforced by increasing environmental allergen levels attributed to climate change and longer pollen seasons reported across multiple continents.

The Immunotherapy segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Immunotherapy segment is predicted to witness the highest growth rate, driven by its unique ability to modify the underlying allergic response rather than temporarily suppressing symptoms. This approach involves administering gradually increasing doses of specific allergens identified through intradermal or serum testing, training the immune system to develop tolerance over time. Treatment protocols typically span twelve to eighteen months but can provide lasting relief after completion, offering superior long-term value compared to lifelong symptomatic management. Advances in sublingual administration, which allows home-based dosing without veterinary visits for injections, are improving treatment adherence and expanding patient eligibility. Veterinary dermatologists increasingly recommend immunotherapy as first-line intervention for moderate to severe environmental allergies.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, sophisticated veterinary infrastructure, and strong consumer spending on companion animal health. The region's advanced veterinary dermatology specialty network provides access to comprehensive allergy testing and customized immunotherapy for pet owners across urban and suburban areas. Major pharmaceutical companies focused on animal health maintain substantial research and commercial operations in the United States, ensuring rapid availability of new treatment options. Pet insurance penetration, while still modest, is higher in North America than most other regions, with several providers offering specific coverage for allergy diagnosis and long-term management protocols.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapidly growing middle-class pet ownership in countries including China, India, and South Korea. Urbanization has increased exposure to environmental pollutants and indoor allergens, while changing lifestyles have intensified human-pet bonds, driving demand for veterinary services comparable to those in Western markets. Veterinary education infrastructure is expanding, with increasing numbers of practitioners pursuing specialization in dermatology and allergy management. International pharmaceutical companies are establishing regional distribution networks and adapting product portfolios for local market needs, including formulations appropriate for regional allergen profiles, positioning Asia Pacific as the fastest-growing frontier for pet allergy care.

Key players in the market

Some of the key players in Pet Allergy Care Market include Zoetis Inc., Elanco Animal Health Incorporated, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Virbac SA, Dechra Pharmaceuticals PLC, Ceva Sante Animale, Heska Corporation, Vetoquinol SA, IDEXX Laboratories, Inc., PetIQ, Inc., Allergan plc, Nestle Purina PetCare Company, Hill's Pet Nutrition, Inc., Royal Canin SAS, Kindred Biosciences, Inc., and Nextmune Holding BV.

Key Developments:

In April 2026, Operating under the Antech/Mars umbrella, the company launched truRapid(TM) FOUR, simplifying the screening for vector-borne diseases. This diagnostic expansion supports the allergy market by helping vets rule out parasitic causes for skin irritation.

In February 2026, Merck Animal Health announced the U.S. FDA approval of NUMELVI(TM) (atinvicitinib tablets), the first and only second-generation JAK inhibitor for dogs. The product is designed to control itch associated with allergic dermatitis in dogs as young as six months, offering higher selectivity for JAK1 to minimize off-target effects.

In February 2026, Elanco received USDA approval for Befrena(TM), a new anti-IL31 monoclonal antibody (mAb) injection for canine allergic and atopic dermatitis. It is recommended for a dosing interval of 6 to 8 weeks, providing a longer-acting alternative to existing monthly injection.

Allergy Types Covered:

Environmental Allergies
Food Allergies
Flea Allergy Dermatitis
Contact Allergies
Other Allergy Types

Treatment Types Covered:

Pharmacological Treatments
Immunotherapy
Topical Treatments
Dietary Management
Other Treatment Types

Route of Administrations Covered:

Oral
Injectable
Topical

Pet Types Covered:

Dogs
Cats
Other Companion Animals

Distribution Channels Covered:

Veterinary Clinics & Hospitals
Retail & Specialty Pet Stores
Online Channels

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Pet Allergy Care Market, By Allergy Type

5.1 Environmental Allergies
5.2 Food Allergies
5.3 Flea Allergy Dermatitis
5.4 Contact Allergies
5.5 Other Allergy Types

6 Global Pet Allergy Care Market, By Treatment Type

6.1 Pharmacological Treatments
- 6.1.1 Antihistamines
- 6.1.2 Corticosteroids
- 6.1.3 Immunomodulators
6.2 Immunotherapy
6.3 Topical Treatments
6.4 Dietary Management
6.5 Other Treatment Types

7 Global Pet Allergy Care Market, By Route of Administration

7.1 Oral
7.2 Injectable
7.3 Topical

8 Global Pet Allergy Care Market, By Pet Type

8.1 Dogs
8.2 Cats
8.3 Other Companion Animals

9 Global Pet Allergy Care Market, By Distribution Channel

9.1 Veterinary Clinics & Hospitals
9.2 Retail & Specialty Pet Stores
9.3 Online Channels

10 Global Pet Allergy Care Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Zoetis Inc.
13.2 Elanco Animal Health Incorporated
13.3 Merck & Co., Inc.
13.4 Boehringer Ingelheim International GmbH
13.5 Virbac SA
13.6 Dechra Pharmaceuticals PLC
13.7 Ceva Sante Animale
13.8 Heska Corporation
13.9 Vetoquinol SA
13.10 IDEXX Laboratories, Inc.
13.11 PetIQ, Inc.
13.12 Allergan plc
13.13 Nestle Purina PetCare Company
13.14 Hill's Pet Nutrition, Inc.
13.15 Royal Canin SAS
13.16 Kindred Biosciences, Inc.
13.17 Nextmune Holding BV

簡介目錄圖表

List of Tables

Table 1 Global Pet Allergy Care Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Pet Allergy Care Market Outlook, By Allergy Type (2023-2034) ($MN)
Table 3 Global Pet Allergy Care Market Outlook, By Environmental Allergies (2023-2034) ($MN)
Table 4 Global Pet Allergy Care Market Outlook, By Food Allergies (2023-2034) ($MN)
Table 5 Global Pet Allergy Care Market Outlook, By Flea Allergy Dermatitis (2023-2034) ($MN)
Table 6 Global Pet Allergy Care Market Outlook, By Contact Allergies (2023-2034) ($MN)
Table 7 Global Pet Allergy Care Market Outlook, By Other Allergy Types (2023-2034) ($MN)
Table 8 Global Pet Allergy Care Market Outlook, By Treatment Type (2023-2034) ($MN)
Table 9 Global Pet Allergy Care Market Outlook, By Pharmacological Treatments (2023-2034) ($MN)
Table 10 Global Pet Allergy Care Market Outlook, By Antihistamines (2023-2034) ($MN)
Table 11 Global Pet Allergy Care Market Outlook, By Corticosteroids (2023-2034) ($MN)
Table 12 Global Pet Allergy Care Market Outlook, By Immunomodulators (2023-2034) ($MN)
Table 13 Global Pet Allergy Care Market Outlook, By Immunotherapy (2023-2034) ($MN)
Table 14 Global Pet Allergy Care Market Outlook, By Topical Treatments (2023-2034) ($MN)
Table 15 Global Pet Allergy Care Market Outlook, By Dietary Management (2023-2034) ($MN)
Table 16 Global Pet Allergy Care Market Outlook, By Other Treatment Types (2023-2034) ($MN)
Table 17 Global Pet Allergy Care Market Outlook, By Route of Administration (2023-2034) ($MN)
Table 18 Global Pet Allergy Care Market Outlook, By Oral (2023-2034) ($MN)
Table 19 Global Pet Allergy Care Market Outlook, By Injectable (2023-2034) ($MN)
Table 20 Global Pet Allergy Care Market Outlook, By Topical (2023-2034) ($MN)
Table 21 Global Pet Allergy Care Market Outlook, By Pet Type (2023-2034) ($MN)
Table 22 Global Pet Allergy Care Market Outlook, By Dogs (2023-2034) ($MN)
Table 23 Global Pet Allergy Care Market Outlook, By Cats (2023-2034) ($MN)
Table 24 Global Pet Allergy Care Market Outlook, By Other Companion Animals (2023-2034) ($MN)
Table 25 Global Pet Allergy Care Market Outlook, By Distribution Channel (2023-2034) ($MN)
Table 26 Global Pet Allergy Care Market Outlook, By Veterinary Clinics & Hospitals (2023-2034) ($MN)
Table 27 Global Pet Allergy Care Market Outlook, By Retail & Specialty Pet Stores (2023-2034) ($MN)
Table 28 Global Pet Allergy Care Market Outlook, By Online Channels (2023-2034) ($MN)